Prognostic factors in myeloma: what they tell us about the pathophysiology of the disease.
about
DNA methylation changes and multiple myeloma.Soluble syndecan-1 at diagnosis and during follow up of multiple myeloma: a single institution study.Soluble IL-6R in plasma cell dyscrasias.Clinical significance of telomerase activity in multiple myeloma.Expression of proliferating cell nuclear antigen (PCNA) in multiple myeloma: its relationship to bone marrow microvessel density and other factors of disease activity.
P2860
Prognostic factors in myeloma: what they tell us about the pathophysiology of the disease.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Prognostic factors in myeloma: ...... athophysiology of the disease.
@en
type
label
Prognostic factors in myeloma: ...... athophysiology of the disease.
@en
prefLabel
Prognostic factors in myeloma: ...... athophysiology of the disease.
@en
P2093
P2860
P1433
P1476
Prognostic factors in myeloma: ...... athophysiology of the disease.
@en
P2093
P2860
P304
P356
10.3109/10428199409049739
P577
1994-11-01T00:00:00Z